Showing results (191-200 of 1,273) with videos related to

Sort By:
Pageof 128
Veterinary and Comparative Oncology|March 13, 2020
Clinicopathological characteristics and prognostic factors for canine multicentric non-indolent T-cell lymphoma: 107 casesKatarzyna Purzycka, Laureen M Peters, Isabelle Desmas, et al.
Veterinary and Comparative Oncology|September 18, 2020
Canine mammary tumours: Size matters-a progression from low to highly malignant subtypesJulia Gedon, Axel Wehrend, Klaus Failing, et al.
Veterinary and Comparative Oncology|January 2, 2021
Prognostic impact of clinical, haematological, and histopathological variables in 102 canine cutaneous perivascular wall tumoursLavinia E Chiti, Roberta Ferrari, Patrizia Boracchi, et al.
Veterinary and Comparative Oncology|December 29, 2020
Reducing margins for abdominopelvic tumours in dogs: Impact on dose-coverage and normal tissue complication probabilityValeria Meier, Chris Staudinger, Stephan Radonic, et al.
Veterinary and Comparative Oncology|October 21, 2020
The oncogenic pathways of papillomavirusesOnur Kaynarcalidan, Tuba Çiğdem Oğuzoğlu
Veterinary and Comparative Oncology|January 28, 2021
KIT mutations in mast cell tumours from cheetahs (Acinonyx jubatus) and domestic cats (Felis catus)Vanessa S Tamlin, Cynthia D K Bottema, Michelle L Campbell-Ward, et al.
Veterinary and Comparative Oncology|January 14, 2021
Evaluation of prognostic impact of pre-treatment neutrophil to lymphocyte and lymphocyte to monocyte ratios in dogs with oral malignant melanoma treated with surgery and adjuvant CSPG4-antigen electrovaccination: an explorative studyMariateresa Camerino, Davide Giacobino, Selina Iussich, et al.
Veterinary and Comparative Oncology|March 22, 2021
Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4-DNA electrovaccination: A retrospective study on 155 casesDavide Giacobino, Mariateresa Camerino, Federica Riccardo, et al.
Veterinary and Comparative Oncology|November 14, 2021
Are severe adverse events commonly observed in dogs during cancer chemotherapy? A retrospective study on 155 dogsThomas Chavalle, Gabriel Chamel, Pauline Denoeux, et al.
Veterinary and Comparative Oncology|January 3, 2022
Novel surgical approach to neoplastic lesions in the distal part of the urethra: A pilot cadaver study comparing open and hybrid techniquesPrzemysław Prządka, Bartłomiej Liszka, Agnieszka Antończyk, et al.
Pageof 128